Age: 57 · Location: Netherlands · Frame: founder-builder-currently-chairing · Judge tier: 1c · Judge Focus-44 rank: 7
Executive Chairman Duomed / Palex (from Nov-2023, IN_SEAT)
_Company: Palex / Duomed Group._
Founded FMH Medical (NL endoscopy); as G Square's Duomed CEO 2017-23 tripled revenue to 600+ staff across ten countries; sold to Palex (Apax/Fremman) 2024.
Founded FMH Medical (NL endoscopy) then Duomed 2017-23 as G Square CEO — tripled revenue to 600+ staff / 10 countries incl. UK entry via GI UK Medical; sold to Palex Oct-2024; now Executive Chairman.
Lin 44-walk: IN_SEAT confirmed Sep-2026. Kit "avail Oct-2026" NOT SUPPORTED. Beheer B.V. = personal holding. Non-compete Oct-2026 UNVERIFIED in public sources.
IN_SEAT — Palex Exec Chairman Sep-2026 (Lin 44-walk CONFIRMED via RocketReach + Duomed press). Kit avail Oct-2026 NOT SUPPORTED. Beheer B.V. = personal holding
Outreach window: TBD (defer pending resolution)
G Square Capital (2017-24 parent) or Houlihan Lokey (Palex sell-side); defer pending Trawl deep-verify of Oct-2026 non-compete claim (UNVERIFIED in public sources)
founder-builder-currently-chairing · Founder-back (pan-European operating model) · L4 bracket ADJACENT · L1=4 L2=4 L4=3 L5=1 L6=3
Path to seat: sold_and_stayed_founder_now_chair
Data gap: Non-compete Oct-2026 UNVERIFIED (kit-claim); current Palex board tie/covenants unknown
Data gap: L6 evidence-only rescore: IN_SEAT Executive Chairman Nov-2023+; LinkedIn personal-holding front is ambiguous — could be 'building next' or just structural